InsiderTrades

Form 4 for CAPR CAPRICOR THERAPEUTICS, INC.

Accepted 2026-06-24 20:00:07 ET · period of report 2026-06-22 · accession 0001593087-26-000011 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-06-24 20:00 2026-06-22+ CAPR Bergmann Anthony CFO M - OptEx $3.18 +900 11.6K +8% +$2,862
DM 2026-06-24 20:00 2026-06-22+ CAPR Bergmann Anthony CFO S - Sale+OE $30.00 -900 11.2K -7% -$27.0K
DM 2026-06-24 20:00 2026-06-22+ CAPR Bergmann Anthony CFO M - OptEx $0.00 -900 116.1K -0.8% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-06-22 M A 500 $3.18 11,723 D — —
2 Common Common Stock 2026-06-22 S D 500 $30.00 11,223 D — — (F1) Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
3 Common Common Stock 2026-06-24 M A 400 $3.18 11,623 D — —
4 Common Common Stock 2026-06-24 S D 400 $30.00 11,223 D — — (F1) Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
5 Derivative Stock Option (Right to Buy) 2026-06-22 M D 500 $0.00 116,480 D $3.18 · — to 2032-01-03 500 Common Stock (F2) Shares vested 1/48th on the first day of each month commencing February 1, 2022.
6 Derivative Stock Option (Right to Buy) 2026-06-24 M D 400 $0.00 116,080 D $3.18 · — to 2032-01-03 400 Common Stock (F2) Shares vested 1/48th on the first day of each month commencing February 1, 2022.